Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

11th August, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub.: Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject, representatives of the Company are participating in Investors’ Meet, as per the below schedule: Date* Investors’ Meeting Place Type of Meeting 14-Aug-26 Emkay - Confluence 2026 Mumbai Group and one on one * The schedule of the above-mentioned meetings is subject to change due to any exigencies on the part of the company or the investors. We request you to kindly take note of the above in pursuance of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com